Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Intresserad av platformen MFN för nyhetsdistribution?

Fredag 14 Mars | 12:59:38 Europe / Stockholm

Svenska | English

BioStock

Cereno Scientific: BioStock: Additional data strengthens Cereno's CS1 in PAH

2025-02-26 11:31:50

Following the promising phase IIa results for its drug candidate CS1 in pulmonary arterial hypertension (PAH) in the fall of 2024, Cereno Scientific now delivers comprehensive data that further reinforce the candidate's potential. The completed clinical study report shows further signs of disease-modifying effects in a disease with limited treatment options.

Read the article at biostock.se:

https://www.biostock.se/en/2025/02/additional-data-strengthens-cerenos-cs1-in-pah/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

BioStock

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden